Bellerophon Therapeutics

Bellerophon Therapeutics

Biotechnology Research

Warren, New Jersey 1,597 followers

About us

Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. Our mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need.

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Warren, New Jersey
Type
Public Company
Founded
2014

Locations

Employees at Bellerophon Therapeutics

Similar pages

Funding

Bellerophon Therapeutics 6 total rounds

Last Round

Post IPO equity

US$ 5.0M

See more info on crunchbase